| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |